How to Read a Beard Minoxidil Study: Sample Size, Placebo, Population, and Hype

Off-label use: Topical minoxidil is FDA-approved only for scalp hair loss; using it on the beard is off-label, so talk to a clinician before you start, especially if you have heart or blood-pressure conditions or take other medications.

Short answer: to judge any beard minoxidil claim, ask seven questions. How many people were studied? Was there a placebo group, and was it blinded? Who were the participants? How long did it run? What exactly was measured? Who paid for it? And was it done on faces or on scalps? The honest picture of beard minoxidil is a few small, placebo-controlled trials in specific populations, plus a 2025 systematic review. That's real evidence, but it's modest. Anything that sounds much bigger probably skipped one of the seven questions.

Context first: topical minoxidil is FDA-approved only for scalp hair loss. Using it on the beard is off-label, which is exactly why the facial studies matter.

1. How many people?

Small studies swing more by chance. If 10 people try something and 7 improve, that could easily be luck. With 100 per group, chance plays a smaller role. Small isn't worthless, though. The two placebo-controlled beard trials had 48 participants (Ingprasert 2016) and 69 participants (Wattanawinitchai 2026). Trials that size can detect a reasonably clear effect, but they can't pin down exactly how big it is, and they can miss rare side effects entirely.

What to look for: the number who finished, not just the number who enrolled. If many dropped out, ask why.

2. Was there a placebo, and was it blinded?

Beards change on their own. Young men's beards often keep filling in through their twenties, and seasons, trim length and lighting change how a beard looks. A placebo group, using an identical-looking product with no active drug, lets researchers separate the drug's effect from everything else.

Blinding matters just as much. If participants or assessors know who got the real drug, expectations can shift how people apply it, how they photograph themselves, and how assessors score the results. Both beard trials describe themselves as placebo-controlled and double-masked or double-blind.

For contrast, a widely cited 2017 scalp study compared a caffeine liquid with 5% minoxidil in 210 men. It was randomized but open-label, meaning everyone knew which product they had. The authors themselves noted this may have introduced bias. We cover that study in our look at minoxidil-free beard serums.

3. Who was studied?

Results apply most directly to people like the participants. Two examples from the beard literature:

• Ingprasert 2016 studied 48 men in Thailand using 3% minoxidil lotion.
• Wattanawinitchai 2026 studied 69 transgender men on testosterone therapy, also in Thailand. People starting testosterone are going through rapid hormonal change, which affects facial hair on its own. A trial in that group answers an important question for trans men, but applying it to cisgender men is an extrapolation. Our breakdown of the 2026 trial goes through the details.

Red flag: a headline or product page that cites a trial without naming who was in it.

4. How long did it run?

Facial hair grows slowly, and minoxidil's effects build over months. A 16-week trial, like Ingprasert's, can show an early effect, but it can't say much about where things stand at a year. Most trials also don't follow people after they stop, so they can't tell you how long gains last. Durability is a separate question. When you read a trial write-up, such as ours on what the 2026 trial showed, check how many weeks of treatment it covered and whether anyone was followed after stopping.

5. What exactly was measured?

Studies measure different things, and they aren't equal:

Also check whether the result was the study's pre-specified main outcome or one of many secondary measures. If a study measures ten things, one may look impressive by chance.

"Significant" isn't the same as "big"

When a paper says a result was "statistically significant," it means the difference between groups was unlikely to be chance alone, given the study's assumptions. It doesn't mean the difference was large or that you'd notice it in a mirror. A small study can miss a real effect. A large study can find a tiny one. Look for:

• The actual size of the difference between drug and placebo, not just the p-value
• A confidence interval, the range of plausible effect sizes. A wide range means the study couldn't pin it down.
• How many people improved in each group, because placebo groups often improve too
• Non-inferiority wording. "Not inferior" means "not worse by more than a margin the researchers chose," which isn't the same as "equally good." The 2017 caffeine scalp trial used a 5% margin on its growth-phase measure.

6. Who paid, and who wrote it?

Industry funding doesn't make a study wrong. Many good trials are industry-funded. But it's a reason to look harder at design choices like open-label designs, surrogate outcomes or non-inferiority margins. The 2017 caffeine-vs-minoxidil scalp trial, for instance, was funded by the caffeine product's maker, and two authors had ties to the sponsor. That's disclosed in the paper. Good studies tell you this; when funding is missing, ask why.

7. Face or scalp?

This is the most common sleight of hand in beard marketing. Scalp hair loss involves follicles shrinking under DHT. A sparse beard usually involves facial follicles that have never fully matured. A scalp result is a hint, not proof, for the face. The rosemary oil claim is a good example: the trial behind it compared rosemary with 2% minoxidil on scalps. See rosemary oil vs minoxidil.

Where reviews, case reports and Reddit fit

• Systematic reviews and meta-analyses pull studies together. They're only as strong as the studies inside them. A review of a few small trials is still a summary of a few small trials. Our summary of the 2025 systematic review explains what it can and can't conclude.
• Case reports, such as a single pair of twins, can raise interesting questions but can't show cause and effect. Our twin case write-up treats it that way.
• Forums and before-and-afters show what's possible for some people. They don't show what's typical. People with great results post more, and lighting, length and angle vary. Our piece on the r/Minoxbeards community discusses what it does and doesn't tell you.

Your checklist

Applying it to your own decision

Reading studies well doesn't make the decision for you, but it sets your expectations. The beard trials suggest minoxidil can do something on faces, under trial conditions, over months, in the people studied. How much it does for you, and whether you get side effects, can't be predicted from them. That's why careful photo tracking, patience, and a conversation with a clinician about off-label use and your heart and blood-pressure history matter more than any headline number.